TOM MURPHY | The Seattle Times

Health and Human Services Secretary Xavier Becerra is interviewed by the Associated Press on Thursday, March 17, 2022, in Washington. (AP Photo/Jacquelyn Martin) DCJM110 DCJM110

May 18, 2022 at 12:58 pm

U.S. health secretary tests positive for COVID on Germany trip

Another member of President Joe Biden’s Cabinet has tested positive for COVID-19. Updated 1:19 pm

May 16, 2022 at 8:00 am

CVS exec: People deserve fair shot at being healthy

The new chief health equity officer at CVS Health hopes she will have more influence in fixing care disparities before they land patients in the...

Business

May 10, 2022 at 4:31 am

Pfizer to spend $11.6B on migraine treatment maker Biohaven

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area.

Business

May 4, 2022 at 8:18 am

Moderna Q1 profit triples on robust COVID vaccine sales

COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter.

Business

May 4, 2022 at 3:55 am

After another strong quarter, CVS raises outlook for 2022

COVID-19 vaccines and tests for the virus continue to boost CVS Health and the health care giant raised its annual forecast after a strong first...

Business

May 3, 2022 at 4:39 am

Change at the top for Biogen after Alzheimer’s drug flops

Biogen is looking for a new CEO less than a year after its launch of its Alzheimer’s drug Aduhelm largely fizzled.

Business

May 3, 2022 at 4:07 am

Pfizer profit soars in first quarter, revises 2022 forecast

Sales of Pfizer’s COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%.

Business

April 28, 2022 at 3:38 am

COVID-19 treatment, Keytruda boost drugmaker Merck in Q1

Merck soared past first-quarter expectations, helped by sales of its long-standing blockbuster cancer drug Keytruda and a new COVID-19 treatment that also topped forecasts.

Business

FILE – This undated photo provided by Merck & Co. shows their new antiviral medication molnupiravir. COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear. U.S. regulators authorized the pills from Pfizer and Merck late 2021. (Merck & Co. via AP, File) NY432 NY432

April 26, 2022 at 11:55 am

Explainer: If you want them to work, COVID-19 pills must be taken within 5 days

COVID-19 patients have two treatment options that can be taken at home. But the pills have to be taken as soon as possible once symptoms...

Business

April 19, 2022 at 4:40 am

J&J suspends COVID-19 vaccine sales forecast

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as...

Business